Wednesday, July 21, 2021 3:40:34 PM
https://www.finviz.com/quote.ashx?t=PRFX
Recent PRFX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 10:25:16 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 03/01/2024 09:34:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/01/2024 01:09:46 PM
- PainReform Provides Year-End Business Update • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/29/2024 09:37:40 PM
- PainReform to Present at the Microcap Conference in Atlantic City • GlobeNewswire Inc. • 01/22/2024 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:30:32 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 01/12/2024 09:15:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 01:36:41 PM
- PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/27/2023 09:04:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 09:01:41 PM
- PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds • GlobeNewswire Inc. • 12/26/2023 11:00:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/15/2023 09:09:02 PM
- PainReform Provides Business Update for the Third Quarter of 2023 • GlobeNewswire Inc. • 11/15/2023 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:41:38 PM
- PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File • GlobeNewswire Inc. • 09/11/2023 12:30:00 PM
- PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary • GlobeNewswire Inc. • 09/07/2023 02:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/05/2023 08:16:34 PM
- PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City • GlobeNewswire Inc. • 09/05/2023 12:30:00 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 08/25/2023 08:15:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/10/2023 08:18:41 PM
- PainReform Provides Business Update for the Second Quarter of 2023 • GlobeNewswire Inc. • 08/10/2023 08:05:00 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM